NCT00552110View on ClinicalTrials.gov

Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)

PHASE2CompletedINTERVENTIONAL
Enrollment

707

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY)

MFNS 2 sprays per nostril with OXY 1 spray per nostril once daily x 2 weeks. Matching placebo to MFNS given every evening (PM).

DRUG

OXY combination: mometasone furoate nasal spray (MFNS) and oxymetazoline nasal spray (OXY)

MFNS 2 sprays per nostril with OXY 3 sprays per nostril once daily x 2 weeks. Matching placebo to MFNS given every evening.

DRUG

mometasone furoate nasal spray (MFNS) once daily

MFNS 2 sprays per nostril once daily x 2 weeks. Matching placebo to MFNS given every morning (AM) and every evening.

DRUG

oxymetazoline nasal spray (OXY) twice daily

OXY 2 sprays per nostril twice daily x 2 weeks. Matching placebo to MFNS given every morning.

DRUG

Placebo

Matching placebo to MFNS given every morning and every evening x 2 weeks.

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00552110 - Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500) | Biotech Hunter | Biotech Hunter